Scandinavian Clinical Nutrition i Sverige AB signed an agreement to acquire Medica Clinical Nord AB from QV Private Equity AB, Bengt Johansson, Karl-Olov Eriksson and others, in stock, on April 25, 2013. The purchase price will be made through a private placement of 98 million shares and an additional payment of maximum 40 million shares if Medica Clinical Nord generates an EBITDA of SEK 11 million for period May 1, 2013 to April 30, 2014. Bengt Johansson and Karl-Olov Eriksson will be included in the management of the new group. Six shares entitle the holder to subscribe for one new share. The rights issue is underwritten by QVPE with the condition that the AGM resolves to complete the acquisition of MCN. Medica Clinical Nord AB reported revenues of SEK 68 million and operating profit of SEK 2 million in 2012. The transaction is subject to approval from shareholders of Scandinavian Clinical Nutrition in an annual general meeting to be held on June 12, 2013 and exemption of QV Private Equity AB from mandatory bid.

Scandinavian Clinical Nutrition i Sverige AB completed the acquisition of Medica Clinical Nord AB from QV Private Equity AB, Bengt Johansson, Karl-Olov Eriksson and others, on April 25, 2014.